[ Back to EurekAlert! ]

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute

John Quackenbush, Ph.D., Dana-Farber Cancer Institute

Caption: John Quackenbush, Ph.D., and colleagues have identified a subtype of ovarian cancer able to build its own blood vessels, suggesting that such tumors might be especially susceptible to anti-angiogenic drugs that block blood vessel formation.

Credit: Sam Ogden

Usage Restrictions: None

Related news release: New subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs


[ Back to EurekAlert! ]